<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title-group><journal-title>Molecular Vision</journal-title></journal-title-group><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">183</article-id><article-id pub-id-type="publisher-id">2009MOLVIS174</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Cone-rod dystrophy and a frameshift mutation in the <italic>PROM1</italic> gene</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Pras</surname><given-names>Eran</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Abu</surname><given-names>Almogit</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rotenstreich</surname><given-names>Ygal</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Avni</surname><given-names>Isaac</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reish</surname><given-names>Orit</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Morad</surname><given-names>Yair</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reznik-Wolf</surname><given-names>Haike</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pras</surname><given-names>Elon</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology, Assaf Harofeh Medical Center, Zerifin, Israel</aff><aff id="aff2"><label>2</label>Gartner Institute of Human Genetics, Sheba Medical Center, Tel Hashomer, Israel</aff><aff id="aff3"><label>3</label>Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer, Israel</aff><aff id="aff4"><label>4</label>Institute of Human Genetics, Assaf Harofeh Medical Center, Zerifin, Israel</aff><aff id="aff5"><label>5</label>Sackler Faculty of Medicine, Tel Aviv University, Israel</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Eran Pras, M.D., Department of Ophthalmology, Assaf Harofeh Medical Center, Zerifin, 70300, Israel; Phone: 972-8-9779358; FAX: 972-3-6354788; email: <email xlink:href="eranpras@gmail.com">eranpras@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>28</day><month>8</month><year>2009</year></pub-date><volume>15</volume><fpage>1709</fpage><lpage>1716</lpage><history><date date-type="received"><day>22</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>24</day><month>8</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>To identify the genetic cause underlying autosomal recessive cone-rod dystrophy (CORD) and high myopia.</p></sec><sec><title>Methods</title><p>Nine members of a consanguineous Arab family were clinically examined and were given fluorescein angiography (FA), biometry, and full field electroretinogram (ERG) testing. Blood samples were collected for DNA extraction. A homozygousity genome-wide scan was performed using &#x0003e;382 polymorphic microsatellite markers on genomic DNA from three affected family members. Regions of homozygosity were further analyzed in all members of the family. Mutation analysis of the <italic>PROM1</italic> gene was performed by direct sequencing of PCR-amplified exons.</p></sec><sec><title>Results</title><p>The phenotype is characterized by severe visual impairment evident in the first decade of life. Affected family members have bull`s-eye macular appearance, peripheral retinal pigment clumps, and cone-rod type ERG changes. Additionally, they have high myopia with axial lengths exceeding 25.3 mm. A genome-wide scan detected a region of 2.1 Mb on chromosome 4p that fully segregates with the disease within the family. This region encompasses the <italic>PROML1</italic> gene, mutations of which have been implicated in retinal dystrophies. <italic>PROML1</italic> mutation analysis identified a novel single nucleotide insertion at position 1629 of the cDNA resulting in truncation of approximately one-third of the protein.</p></sec><sec><title>Conclusions</title><p>The mutation described in this report further expands the clinical spectrum of <italic>PROM1</italic> mutations.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Pras</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Retinal dystrophies display a high degree of clinical and genetic heterogeneity. Frequently, a single disease may be caused by mutations in different genes, and in some cases, mutations in a single gene may lead to clinically distinct diseases. An example of the latter are mutations in the <italic>ABCA4</italic> gene, which were previously associated with Stargardt disease (STGD; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=248200">248200</ext-link>), retinitis pigmentosa (RP; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=268000">268000</ext-link>), and cone-rod dystrophy (CORD; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604116">604116</ext-link> or <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=120970">120970</ext-link>) [<xref ref-type="bibr" rid="r1">1</xref>]. CORDs are progressive retinal disorders, characterized by simultaneous involvement of both cone and rod photoreceptor cells [<xref ref-type="bibr" rid="r2">2</xref>-<xref ref-type="bibr" rid="r4">4</xref>]. They are heterogeneous in terms of clinical manifestations, the hereditary pattern, and causative genes (<ext-link ext-link-type="uri" xlink:href="http://www.sph.uth.tmc.edu/Retnet">RETNET</ext-link>) [<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r6">6</xref>]. Significant differences in onset age and disease severity have been documented even within a single family [<xref ref-type="bibr" rid="r7">7</xref>]. Usually they present at childhood with cone dysfunction-related symptoms, including decreased visual acuity, photophobia, impaired color vision, and nystagmus. With time, poor night vision and restricted peripheral visual fields develops, reflecting rod photoreceptor involvement. Typical fundus changes in CORDs in the early stages are characterized by macular atrophy and retinal pigmenent epithelium changes. However with disease progress, pigmentation resembling RP appear in retinal periphery. Full field electroretinography (ERG) testing is abnormal with either cone (photopic) responses more reduced than rod (scotopic) responses, or equally reduced cone and rod systems [<xref ref-type="bibr" rid="r2">2</xref>-<xref ref-type="bibr" rid="r7">7</xref>].</p><p>PROM1 (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604365">604365</ext-link>) is a membrane glycoprotein specifically concentrated in various membrane structures that protrude from the planar areas of the plasmatic membrane. It binds to the plasma membrane cholesterol and is associated with a particular membrane microdomain in a cholesterol-dependant manner [<xref ref-type="bibr" rid="r8">8</xref>]. It has a unique membrane topology with five transmembrane spanning segments and two large N-glycosylated extracellular loops [<xref ref-type="bibr" rid="r9">9</xref>]. Several splice variants affecting the protein sequence have been identified with a broad range of expression [<xref ref-type="bibr" rid="r10">10</xref>]. Yet it is on the visual system where interference with its function has the most obvious effect. PROM1 is expressed in both types of photoreceptors. Mutations have previously been implicated in both RP families where rod dysfunction predominates [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>] and in macular dystrophy families where cones are mostly affected [<xref ref-type="bibr" rid="r13">13</xref>]. Mounting evidence assigns a critical role for PROM1 in the morphogenesis of new disc membranes in photoreceptor&#x02019;s outer segments [<xref ref-type="bibr" rid="r11">11</xref>-<xref ref-type="bibr" rid="r13">13</xref>]. We describe a consanguineous Arab family who has a novel PROM1 mutation that functionally disrupts both types of photoreceptors and presents as cone-rod dystrophy.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients and methods</title><p>A consanguineous Arab family (Pedigree 42001) was ascertained at Assaf Harofeh Medical Center (<xref ref-type="fig" rid="f1">Figure 1</xref>). The parents are first degree cousins and three of their seven children suffer from severe visual impairment evident at the first year of life. Subsequent ophthalmic examinations led to the diagnosis of CORD. The protocol of the study adhered to the provisions of the Declaration of Helsinki, and after obtaining informed consent from the participants, DNA was extracted from peripheral blood using a commercial kit (Gentra System Inc., Minneapolis, MN). Fifty DNA samples of Israeli Arab subjects without any known ocular diseases were used as controls.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p>Family pedigree and haplotypes surrounding the PROM1 locus. Shown are nine chromosome 4 microsatellite markers allele readings, and the <italic>PROM1</italic> c.1349insT change (allele 2). The marker order is to the left of each generation. Filled symbols indicate affected individuals; open symbols indicate unaffected individuals; and filled bars indicate carrier haplotypes.</p></caption><graphic xlink:href="mv-v15-1709-f1"/></fig></sec><sec><title>Clinical assessment</title><p>A full medical history was obtained and standard ophthalmologic examinations including best-corrected visual acuity measurements, slit-lamp biomicroscopy and color vision tests were performed in all family members. The patients also underwent kinetic visual fields, color fundus photography, flourescein angiography (FA), and full-field ERG scans which were obtained from both eyes of each patient by following the protocol of the International Society for Clinical Electrophysiology of Vision (ISCEV; LKC Technologies, Gaithersburg, MD) [<xref ref-type="bibr" rid="r14">14</xref>]. The diagnosis of CORD in this study was based on the following criteria: reduced visual acuity and nystagmus evident at infancy, impairment of color vision, fundoscopic evidence of maculopathy with peripheral retinopathy, and the demonstration of a cone-rod pattern ERG.</p></sec><sec><title>Molecular biology</title><p>A homozygosity genome-wide scan was performed on DNA samples from the three affected individuals using a commercial genotyping service (Laboratory of DNA Analysis at the Institute of Life Sciences, Hebrew University of Jerusalem). A total of 382 microsatellites spaced at approximately 10 cM intervals were analyzed using the MD-10 linkage mapping set (ABI MD-10; Applied Biosystems, Foster City CA). Regions that showed homozygous readings in the initial scan were further evaluated with additional polymorphic markers, for segregation in the entire family as previously described [<xref ref-type="bibr" rid="r15">15</xref>]. The entire coding region and exon-intron boundaries of the <italic>PROM1</italic> gene were amplified using 25 pairs of primers (<xref ref-type="table" rid="t1">Table 1</xref>), and sequenced with ABI BigDye Terminator cycle sequencing kit v3.1 (Applied Biosystems) according to manufacturer&#x02019;s instructions. The mutation was confirmed and analyzed on an automated ABI Prism 3100 Genetic Analyzer (Perkin Elmer, Waltham, MA) using the fluorescent primer pairs 5&#x02032;-CTA ACA CTG TGC TTG CCT CTC-3&#x02032; and 5&#x02032;-ACT CAC ACC ATG AGG AAG ACG-3&#x02032;.</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Forward and reverse primers for PCR amplification of <italic>PROM1</italic> exons.</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="231" span="1"/><col width="227" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Exon number</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Forward primer (5&#x02032;-3&#x02032;)</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Reverse primer (5&#x02032;-3&#x02032;)</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GAAGATTCAGCAGATCCAGTGCT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CATTCCTCGCAACCTATGTAACC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">2<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGGCTTCTGGCTAGAGGTCATTA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGGTTCAAATGGGATTTGTAAGG<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">3<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TTCCTCCTTGTGGGATATGAATG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGAACAAGATACGGCATTTCAAG<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AAAAGAACTTTGTACACCATGGAATG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGCAGCTTCATTACAACGCTAAT<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGAGTCCTGTTTTGTAGCCCCTA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CACCAGTCTACGCTGATTCACTG<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GCTGGTTACCTGAAAATGTCCTG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GACACATTGGCAATAAGGCTAGG<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">7<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCAAGATGATAACACCATGCTCCT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ATCATCTGAAATGGCAACAGCTT<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">8<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TGGAAGAGTGGAGCTAGTTGGAG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTTTTACTCCTTTGCTCCTGCTG<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">9<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CAAAAGAAACTGCGATTGTACCC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTTAGCATGCCACTTCACACATC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGGACCCCCTATATGAAAAACTTC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TCCGAATGACACAATTGTAAAGC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">11<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TAAAGTCAGTGCTCACAGCTTGC<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ATGCGAACCTTCTATGCATTGTT<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">12<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACCAGGAACAATGCAAACCTAGA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGCTTGACAGAAGTACCCAAATC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">13<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AGGTGGATGATCTGTTTCACCTG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AACTGCTTATAAGTTTGCACTGCTCT<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">14<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GTTGGAAATCAACCAGAAAAATAATG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCAGAGATTATTGGAGAGCGAGA<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">15<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CAAGGCAAGAAGTCAGAAGTGGT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CGTTTTGGAACCAAATAGAGGTG<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">16<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCACATCCAGCTTTTATTGCTCT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GAAGTAGTTGTGCAGCACTGTGAA<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">17<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CAAATGTTGCCACCTGTTTAAGA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GACGGAAACGTAATGACACACAC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">18<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GAGAGTCCATGGTTCTGTGCTTT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CAGAGGGAGGTGCAATTATTTTG<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">19<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TTTGATGGCTATCTTGTGGGAAG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CCTGCTAAGATGAGGTCTGCACT<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">20&#x02013;21<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">GGTGTTGCAGAGCTGAGTTACAG<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">AAGTCTTGGTCCTGCACATCAAT<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">22<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TATCCATCTGTGACCCAGGAGTT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CGCCCAGAACTTTGACTTTTCTA<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">23<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">CTGGTCCACATGACATTCTCAAA<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACAGCACCACCTAGAAAATGACC<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">24&#x02013;25<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">TTTGCACTGTCAGTATCCGTGTT<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">ACTCATGGCATCATGGAACACTA<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">26</td><td valign="top" align="left" rowspan="1" colspan="1">ACCTTTAGTCACATGCCTGCTTC</td><td valign="top" align="left" rowspan="1" colspan="1">AGGTACAGAGGGTGGACTGGAC</td></tr></tbody></table></table-wrap></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Clinical examination</title><p>The ocular examination in all three affected patients revealed early macular involvement accompanied by growing rod-related dysfunction and high myopia (<xref ref-type="table" rid="t2">Table 2</xref>). Central visual dysfunction was apparent at early childhood manifested by nystagmus, mild photophobia, color vision deficiency, and poor visual acuity ranging from finger counting to 6/60. None of these findings were found in the parents or unaffected siblings. Night vision deteriorated in the late teens. The degree of the myopia was high with axial lengths exceeding 25.3&#x000a0;mm. On fundus examination and FA, changes consistent with bull&#x02019;s-eye macular degeneration (<xref ref-type="fig" rid="f2">Figure 2A,B,D,E</xref>) were documented as early as 15 years of age, whereas retinal periphery appeared to be preserved with only occasional pigment deposits (<xref ref-type="fig" rid="f2">Figure 2C</xref>). Goldman visual field testing demonstrated constricted peripheral visual field isopters and reduced central sensitivity (<xref ref-type="fig" rid="f2">Figure 2F-G</xref>). These are in line with the full field ERG findings, which showed nondetectable photopic single flash or flicker 30 Hz stimulus responses representing severe cone-derived functions. Rod-derived measurements under scotopic backgrounds revealed a residual but markedly abnormal result (<xref ref-type="fig" rid="f3">Figure 3</xref>). There was no evidence of keratoconus, hearing loss, polydactyly, or any systemic abnormalities. Taken together, the association of symptoms, ophthalmoscopy findings, and visual function tests were all consistent with CORD and high myopia.</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Clinical details on affected individuals in family 42001</title></caption><table frame="hsides" rules="groups"><col width="57" span="1"/><col width="49" span="1"/><col width="46" span="1"/><col width="76" span="1"/><col width="94" span="1"/><col width="117" span="1"/><col width="67" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>ID</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Gender</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Age</bold>&#x02028;<bold>(years)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Onset age</bold>&#x02028;<bold>(years)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Visual acuity (OD;OS)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Myopia</bold>&#x02028;<bold>(Axial length; OD;OS)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Nystagmus</bold></th></tr></thead><tbody><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">4200103<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Early childhood<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CF; CF<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;11 dpt (26 mm); &#x02212;10 dpt (25.8 mm)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Yes<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">4200105<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">25<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Early childhood<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">CF; CF<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;8.0 dpt (25.3 mm); &#x02212;9.0 dpt (25.5 mm)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">Yes<hr/></td></tr><tr><td valign="top" align="center" scope="row" rowspan="1" colspan="1">4200107</td><td valign="top" align="center" rowspan="1" colspan="1">M</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">Early childhood</td><td valign="top" align="center" rowspan="1" colspan="1">6/120; 6/60</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;10 dpt (25.5 mm); &#x02212;10 dpt (25.5 mm)</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td></tr></tbody></table><table-wrap-foot><p>The table provides information regarding the symptoms experienced by the affected CORD patients. Three family 42001 individuals suffer from severe impairment of visual acuity, nystagmus, and high axial myopia evident at early childhood. Abbreviations: diopters (dpt); counting fingers at a distance ranging from 1 to3&#x000a0;m (CF).</p></table-wrap-foot></table-wrap><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Clinical finding&#x02019;s in CORD family 42001. Clinical pictures from affected family members showing classical features of CORD. Fundus photographs from individual 4200103 aged 19. Bull&#x02019;s-eye macular atrophy is shown in photographs <bold>A</bold> (right eye), <bold>B</bold> (left eye), and <bold>D</bold> (left eye &#x0201c;red-free&#x0201d; photograph). The macula in this individual has a peri-foveal ring of RPE hypertrophy bordered centrally and peripherally with RPE atrophy. Fluorescein angiogram imaging demonstrating a ring of block-fluorescence by the RPE hypertrophy, bordered centrally and peripherally by hyper-fluorescence, due to RPE atrophy (&#x0201c;window-defect&#x0201d;; right eye- <bold>E</bold>, and left eye- <bold>F</bold>). &#x0201c;Red-free&#x0201d; imaging of peripheral retina, demonstrates pigment clumps (<bold>C</bold>). Goldman perimetry from family member 4200105 exhibiting concentric constriction of visual fields to 40 degrees temporally, and 30 degrees nasally. Red isopter&#x02019;s stimulus is IVe4, blue isopter&#x02019;s stimulus is IVe3 and a green isopters stimulus is IVe2 (Left eye <bold>G</bold> and right eye <bold>H</bold>).</p></caption><graphic xlink:href="mv-v15-1709-f2"/></fig><fig id="f3" fig-type="figure" position="float"><label>Figure 3</label><caption><p>Electroretinogram studies. Shown are scotopic and photopic ERG responses from one affected family member (4200105; left column) and a normal control (right column). The cone-derived responses in the affected family member revealed neither detectable single flash photopic response nor flicker 30 Hz response(<bold>C</bold>, <bold>D</bold>). Assessment of the rod-derived functions by the scotopic single flash test show a detectable but markedly abnormal respond, (<bold>A</bold>, <bold>B</bold>). These findings are consistent with CORD.</p></caption><graphic xlink:href="mv-v15-1709-f3"/></fig></sec><sec><title>Segregation analysis and mutation detection</title><p>The initial genome scan detected 11 microsatellite markers that shared homozygous allele readings in all 3 affected family members (D4S2935, D4S403, D6S158, D7S516, D7S484, D9S171, D9S287, D19S197, D11S925, D13S171, and D16S3091). Of these D4S2935, D4S403, and D7S516, D7S484 were consecutive, and therefore were thought to represent larger regions of homozygosity. When these regions were analyzed in the entire family with additional markers, only the chromosome 4p locus demonstrated full segregation. The 2.1 Mb critical interval was flanked by a telomeric obligate recombination in family member 4200103 for the marker UniSTS:1230568 (14.8 Mb) and a centromeric recombination in family member 4200105 for UniSTS:1230565 (16.9 Mb; <xref ref-type="fig" rid="f1">Figure 1</xref>). The interval contains ten known genes including <italic>PROM1</italic> (15.57 Mb). Sequencing of the 26 coding exons of PROM1 in one of the patients disclosed a homozygous insertion in exon 12 (c.1349insT; <xref ref-type="fig" rid="f4">Figure 4A</xref>), which results in a frame-shift starting at codon 452 and a putative stop codon 12 amino acids downstream in the translated protein (p.Y452fs12X).</p><fig id="f4" fig-type="figure" position="float"><label>Figure 4</label><caption><p>Molecular studies. <bold>A</bold>: Sequence chromatogram from a normal subject (top) and a CORD patient (bottom) with a homozygous insertion of T at position 1349 of the cDNA (c.1349insT) which results in a frame-shift starting at codon 452 and a putative stop codon 12 amino acids downstream in the translated protein (p.Y452fs12X). <bold>B</bold>: ABI 3100 assay for the detection of the <italic>PROM1</italic> mutation. The 1bp difference is evident in the homozygotes (reading peak at 201 bp) compared to controls (reading peak at 200 bp). Heterozygotes appear as two peaks.</p></caption><graphic xlink:href="mv-v15-1709-f4"/></fig><p>The mutation was confirmed, then extended to other family members by visualization of the 1 bp difference on an automated ABI Prism 3100 Genetic Analyzer (<xref ref-type="fig" rid="f4">Figure 4B</xref>).None of the other family members were homozygous for the mutation. Screening of 100 control chromosomes from Arab descent revealed only the wild-type allele.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>We describe three siblings from a consanguineous Arab family who had central visual loss since childhood, night blindness, visual fields constriction, and high myopia. Electrophysiology studies and funduscopic examinations were consistent with CORD. A novel homozygous frameshift mutation was observed in PROM1. The mutation showed full segregation within the family and was not detected in a population of matched controls.</p><p>A striking feature of the disease in this family is the presence of axial myopia. High myopia which accompanies retinal dystrophies is characterized by an early age of onset, a high degree of refractive error, and is considered to have an underling hereditary etiology. It is plausible that the <italic>PROM1</italic> mutation may have contributed for both CORD and high myopia in this family. However absence of myopia in the other <italic>PROM1</italic>-related phenotypes and lack of <italic>PROM1</italic> expression in the sclera argues against <italic>PROM1</italic> involvement in the pathogenesis of the myopia. Another possibility is that the myopia and CORD are caused by mutations in two independent genes that are tightly linked. In such a case the neighboring gene fibroblast growth factor binding protein-1 (<italic>FGFBP1</italic>; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=607737">607737</ext-link>), located approximately 30 kb from <italic>PROM1</italic>, is a potential candidate gene for the observed myopia. A third possibility is that the myopia seen in our CORD patients may simply be induced by blurred vision. Vision deprivation has been reported to induce myopia in the chicken, mouse, and monkey [<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. Many previous studies have reported a high prevalence of myopia among patients with retinal dystrophy [<xref ref-type="bibr" rid="r18">18</xref>].</p><p>Interestingly, deleterious <italic>PROM1</italic> mutations were described by Maw et al. and Zhang et al. in 2000 and 2007 respectively, in autosomal recessive RP families [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>]. The patients in these RP families differ from ours in several aspects. While visual night functions were initially spared in our patients, night blindness was the presenting symptom in the families described by Maw and Zhang, and they did not suffer photophoibia or myopia. Moreover, their fundus examination revealed typical RP findings of waxy-pale discs, obvious attenuation of blood vessels, and typical bone-spicule pigmentation in the mid-peripheral retina. Finally, in contrast to our family, their ERG recordings did not detect any rod responses. Despite these differences, the manifestations of all three families with deleterious <italic>PROM1</italic> mutations, demonstrate a gradually evolving rod and cone deterioration. All patients presented at childhood and experienced severe progression of the disease, an observation that emphasizes a key role for <italic>PROM1</italic> in the maintenance and function of rods and cones.</p><p>In contrast to the recessive inheritance mentioned, three families with a <italic>PROM1</italic> missense mutation (R373C) and autosomal dominant inheritance have also been described [<xref ref-type="bibr" rid="r13">13</xref>]. Two of these families had a Stargardt-like macular dystrophy (STGD4; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=603786">603786</ext-link> [<xref ref-type="bibr" rid="r19">19</xref>]) and bull&#x02019;s eye macular dystrophy (MCDR2; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=608051">608051</ext-link> [<xref ref-type="bibr" rid="r20">20</xref>]), while a third family has only been mentioned briefly to have autosomal dominant cone-rod dystrophy without supplement phenotypic description.</p><p>Based on the data presented in our study, it is evident that mutations in <italic>PROM1</italic> are associated with a wide variety of symptoms ranging from mild autosomal dominant macular degenerations, via CORD, to severe autosomal recessive RP. How could this diversity be explained? The severe frameshift and null mutations observed in the recessive RP and CORD most likely abolish the function of one allele leading to lack of protein production from that allele. However a single functioning allele is sufficient to maintain normal retinal activity; only when both alleles are lacking do disease symptoms develop. In contrast, missense mutations result in a mutant protein that also interferes with the action of the normal protein, exerting a negative dominant effect and explaining the autosomal dominant inheritance. Indeed, immunohistochemistry studies in transgenic mice carrying the R373C mutation revealed that not only the mutant protein was mislocalized but it also caused the mislocalization of the wild-type protein. The mutant protein also impaired the function of two other proteins that are essential for photoreceptor integrity: Protocadherin 21 (PCDH21; OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=609502">609502</ext-link>) [<xref ref-type="bibr" rid="r21">21</xref>] and the cytoskeletal actin filament [<xref ref-type="bibr" rid="r22">22</xref>]. The observed interactions between PROM1and other proteins involved in the photoreceptors disk formation and maintenance unravel the complexity of this process and may account, at least in part, for the phenotypic variation. Most likely additional background genes and environmental factors are also involved.</p><p>The mutation described in this report further expands the clinical spectrum of <italic>PROM1</italic> mutations.</p></sec></body><back><ack><title>Acknowledgments</title><p>This research was supported by the Claire and Amedee Martier Institute for the Study of Blindness and Visual Disorders, Sackler Faculty of Medicine, Tel Aviv University. We thank members of the family for their participation, and Mrs. Dina Marek-Yagel for her valuable support in preparing this manuscript.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cremers</surname><given-names>FP</given-names></name><name><surname>van de Pol</surname><given-names>DJ</given-names></name><name><surname>van Driel</surname><given-names>M</given-names></name><name><surname>den Hollander</surname><given-names>AI</given-names></name><name><surname>van Haren</surname><given-names>FJ</given-names></name><name><surname>Knoers</surname><given-names>NV</given-names></name><name><surname>Tijmes</surname><given-names>N</given-names></name><name><surname>Bergen</surname><given-names>AA</given-names></name><name><surname>Rohrschneider</surname><given-names>K</given-names></name><name><surname>Blankenagel</surname><given-names>A</given-names></name><name><surname>Pinckers</surname><given-names>AJ</given-names></name><name><surname>Deutman</surname><given-names>AF</given-names></name><name><surname>Hoyng</surname><given-names>CB</given-names></name></person-group><article-title>Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR.</article-title><source>Hum Mol Genet</source><year>1998</year><volume>7</volume><fpage>355</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">9466990</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berson</surname><given-names>EL</given-names></name><name><surname>Gouras</surname><given-names>P</given-names></name><name><surname>Gunkel</surname><given-names>R</given-names></name></person-group><article-title>Progressive cone-rod degeneration.</article-title><source>Arch Ophthalmol</source><year>1968</year><volume>80</volume><fpage>68</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">5660020</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>AT</given-names></name></person-group><article-title>Cone and cone-rod dystrophies.</article-title><source>J Med Genet</source><year>1992</year><volume>29</volume><fpage>289</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">1583653</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckenlively</surname><given-names>JR</given-names></name></person-group><article-title>RP cone-rod degeneration.</article-title><source>Trans Am Ophthalmol Soc</source><year>1987</year><volume>85</volume><fpage>438</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">3447340</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szlyk</surname><given-names>JP</given-names></name><name><surname>Fishman</surname><given-names>GA</given-names></name><name><surname>Alexander</surname><given-names>KR</given-names></name><name><surname>Peachey</surname><given-names>NS</given-names></name><name><surname>Derlacki</surname><given-names>DJ</given-names></name></person-group><article-title>Clinical subtypes of cone-rod dystrophy.</article-title><source>Arch Ophthalmol</source><year>1993</year><volume>111</volume><fpage>781</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8512479</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagasaki</surname><given-names>K</given-names></name><name><surname>Jacobson</surname><given-names>SG</given-names></name></person-group><article-title>Cone-rod dystrophy: phenotypic diversity by retinal function testing.</article-title><source>Arch Ophthalmol</source><year>1989</year><volume>107</volume><fpage>701</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2719580</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udar</surname><given-names>N</given-names></name><name><surname>Yelchits</surname><given-names>S</given-names></name><name><surname>Chalukya</surname><given-names>M</given-names></name><name><surname>Yellore</surname><given-names>V</given-names></name><name><surname>Nusinowitz</surname><given-names>S</given-names></name><name><surname>Silva-Garcia</surname><given-names>R</given-names></name><name><surname>Vrabec</surname><given-names>T</given-names></name><name><surname>Hussles Maumenee</surname><given-names>I</given-names></name><name><surname>Donoso</surname><given-names>L</given-names></name><name><surname>Small</surname><given-names>KW</given-names></name></person-group><article-title>Identification of GUCY2D gene mutations in CORD5 families and evidence of incomplete penetrance.</article-title><source>Hum Mutat</source><year>2003</year><volume>21</volume><fpage>170</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">12552567</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>N</given-names></name><name><surname>Fonseca</surname><given-names>A-V</given-names></name><name><surname>Florek</surname><given-names>M</given-names></name><name><surname>Freund</surname><given-names>D</given-names></name><name><surname>Jaszai</surname><given-names>J</given-names></name><name><surname>Bornhauser</surname><given-names>M</given-names></name><name><surname>Fargeas</surname><given-names>CA</given-names></name><name><surname>Corbeil</surname><given-names>D</given-names></name></person-group><article-title>New Insights into the Cell Biology of Hematopoietic Progenitors by Studying Prominin-1 (CD133).</article-title><source>Cells Tissues Organs</source><year>2008</year><volume>188</volume><fpage>127</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">18160824</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e1;szai</surname><given-names>J</given-names></name><name><surname>Fargeas</surname><given-names>CA</given-names></name><name><surname>Florek</surname><given-names>M</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Corbeil</surname><given-names>D</given-names></name></person-group><article-title>Focus on molecules: prominin-1 (CD133).</article-title><source>Exp Eye Res</source><year>2007</year><volume>85</volume><fpage>585</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16733052</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fargeas</surname><given-names>CA</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Corbeil</surname><given-names>D</given-names></name></person-group><article-title>Nomenclature of prominin-1 (CD133) splice variants - an update.</article-title><source>Tissue Antigens</source><year>2007</year><volume>69</volume><fpage>602</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17498271</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maw</surname><given-names>MA</given-names></name><name><surname>Corbeil</surname><given-names>D</given-names></name><name><surname>Koch</surname><given-names>J</given-names></name><name><surname>Hellwig</surname><given-names>A</given-names></name><name><surname>Wilson-Wheeler</surname><given-names>JC</given-names></name><name><surname>Bridges</surname><given-names>RJ</given-names></name><name><surname>Kumaramanickavel</surname><given-names>G</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Nancarrow</surname><given-names>D</given-names></name><name><surname>Roper</surname><given-names>K</given-names></name><name><surname>Weigmann</surname><given-names>A</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Denton</surname><given-names>MJ</given-names></name></person-group><article-title>A frameshift mutation in prominin (mouse)-like 1 causes human retinal degeneration.</article-title><source>Hum Mol Genet</source><year>2000</year><volume>9</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">10587575</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zulfiqar</surname><given-names>F</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Riazuddin</surname><given-names>SA</given-names></name><name><surname>Ahmad</surname><given-names>Z</given-names></name><name><surname>Caruso</surname><given-names>R</given-names></name><name><surname>MacDonald</surname><given-names>I</given-names></name><name><surname>Sieving</surname><given-names>P</given-names></name><name><surname>Riazuddin</surname><given-names>S</given-names></name><name><surname>Hejtmancik</surname><given-names>JF</given-names></name></person-group><article-title>Severe retinitis pigmentosa mapped to 4p15 and associated with a novel mutation in the PROM1 gene.</article-title><source>Hum Genet</source><year>2007</year><volume>122</volume><fpage>293</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17605048</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Lillo</surname><given-names>C</given-names></name><name><surname>Chien</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Michaelides</surname><given-names>M</given-names></name><name><surname>Klein</surname><given-names>M</given-names></name><name><surname>Howes</surname><given-names>KA</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Kaminoh</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Al-Sheikh</surname><given-names>YT</given-names></name><name><surname>Karan</surname><given-names>G</given-names></name><name><surname>Corbeil</surname><given-names>D</given-names></name><name><surname>Escher</surname><given-names>P</given-names></name><name><surname>Kamaya</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Frederick</surname><given-names>JM</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Cameron</surname><given-names>DJ</given-names></name><name><surname>Huttner</surname><given-names>WB</given-names></name><name><surname>Schorderet</surname><given-names>DF</given-names></name><name><surname>Munier</surname><given-names>FL</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name><name><surname>Birch</surname><given-names>DG</given-names></name><name><surname>Baehr</surname><given-names>W</given-names></name><name><surname>Hunt</surname><given-names>DM</given-names></name><name><surname>Williams</surname><given-names>DS</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name></person-group><article-title>Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice.</article-title><source>J Clin Invest</source><year>2008</year><volume>118</volume><fpage>2908</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">18654668</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marmor</surname><given-names>MF</given-names></name><name><surname>Holder</surname><given-names>GE</given-names></name><name><surname>Seeliger</surname><given-names>MW</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name></person-group><article-title>Standard for clinical electroretinography (2004 update).</article-title><source>Doc Ophthalmol</source><year>2004</year><volume>108</volume><fpage>107</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15455793</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eran</surname><given-names>P</given-names></name><name><surname>Almogit</surname><given-names>A</given-names></name><name><surname>David</surname><given-names>Z</given-names></name><name><surname>Wolf</surname><given-names>HR</given-names></name><name><surname>Hana</surname><given-names>G</given-names></name><name><surname>Yaniv</surname><given-names>B</given-names></name><name><surname>Elon</surname><given-names>P</given-names></name><name><surname>Isaac</surname><given-names>A</given-names></name></person-group><article-title>The D144E substitution in the VSX1 gene: a non-pathogenic variant or a disease causing mutation?</article-title><source>Ophthalmic Genet</source><year>2008</year><volume>29</volume><fpage>53</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">18484309</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>EL</given-names><suffix>3rd</suffix></name><name><surname>Hung</surname><given-names>LF</given-names></name><name><surname>Kee</surname><given-names>CS</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name></person-group><article-title>Effects of brief periods of unrestricted vision on the development of form-deprivation myopia in monkeys.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2002</year><volume>43</volume><fpage>291</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11818369</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tejedor</surname><given-names>J</given-names></name><name><surname>de la Villa</surname><given-names>P</given-names></name></person-group><article-title>Refractive changes induced by form deprivation in the mouse eye.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>32</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12506052</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowski</surname><given-names>B</given-names></name><name><surname>Zrenner</surname><given-names>E</given-names></name></person-group><article-title>Cone and rod function in cone degenerations.</article-title><source>Vision Res</source><year>1997</year><volume>37</volume><fpage>2303</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">9578911</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kniazeva</surname><given-names>MF</given-names></name><name><surname>Chiang</surname><given-names>MF</given-names></name><name><surname>Cutting</surname><given-names>GR</given-names></name><name><surname>Zack</surname><given-names>DJ</given-names></name><name><surname>Han</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>KS</given-names></name></person-group><article-title>Clinical and genetic studies of an autosomal dominant cone-rod dystrophy with features of Stargardt disease.</article-title><source>Ophthalmic Genet</source><year>1999</year><volume>20</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10420191</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelides</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Poulson</surname><given-names>A</given-names></name><name><surname>Bradshaw</surname><given-names>K</given-names></name><name><surname>Bellmann</surname><given-names>C</given-names></name><name><surname>Hunt</surname><given-names>DM</given-names></name><name><surname>Moore</surname><given-names>AT</given-names></name></person-group><article-title>An autosomal dominant bull's-eye macular dystrophy (MCDR2) that maps to the short arm of chromosome 4.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2003</year><volume>44</volume><fpage>1657</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">12657606</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rattner</surname><given-names>A</given-names></name><name><surname>Smallwood</surname><given-names>PM</given-names></name><name><surname>Williams</surname><given-names>J</given-names></name><name><surname>Cooke</surname><given-names>C</given-names></name><name><surname>Savchenko</surname><given-names>A</given-names></name><name><surname>Lyubarsky</surname><given-names>A</given-names></name><name><surname>Pugh</surname><given-names>EN</given-names></name><name><surname>Nathans</surname><given-names>J</given-names></name></person-group><article-title>A photoreceptor-specific cadherin is essential for the structural integrity of the outer segment and for photoreceptor survival.</article-title><source>Neuron</source><year>2001</year><volume>32</volume><fpage>775</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">11738025</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughan</surname><given-names>DK</given-names></name><name><surname>Fisher</surname><given-names>SK</given-names></name></person-group><article-title>Cytochalasin D disrupts outer segment disc morphogenesis in situ in rabbit retina.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1989</year><volume>30</volume><fpage>339</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">2914762</pub-id></mixed-citation></ref></ref-list></back></article>